检验医学 ›› 2021, Vol. 36 ›› Issue (7): 710-713.DOI: 10.3969/j.issn.1673-8640.2021.07.006

• 临床应用研究·论著 • 上一篇    下一篇

孕妇梅毒血清学筛查流程探讨

齐结华, 张春利, 吴守乐, 宦宇, 陈宇, 乐江漫, 蔡徐山()   

  1. 上海市嘉定区妇幼保健院检验科,上海 201821
  • 收稿日期:2020-10-27 出版日期:2021-07-30 发布日期:2021-07-26
  • 通讯作者: 蔡徐山
  • 作者简介:蔡徐山,E-mail: cai139149@126.com
    齐结华,男,1983年生,学士,主管技师,主要从事临床免疫学检验工作。
  • 基金资助:
    上海市嘉定区卫生健康委员会资助项目(2017-KY-18)

Investigation on the process of serological screening for syphilis in pregnant women

QI Jiehua, ZHANG Chunli, WU Shoule, HUAN Yu, CHEN Yu, LE Jiangman, CAI Xushan()   

  1. Department of Clinical Laboratory,the Maternal and Child Health Hospital of Jiading District,Shanghai 201821,China
  • Received:2020-10-27 Online:2021-07-30 Published:2021-07-26
  • Contact: CAI Xushan

摘要:

目的 探讨孕妇梅毒血清学筛查流程。方法 收集经化学发光法(CLIA)筛查抗梅毒螺旋体(TP)抗体S/CO值≥1.0的548例孕妇的血清样本。分别采用化学发光微粒子免疫分析法(CMIA)、甲苯胺红不加热血清试验(TRUST)和免疫印迹法进行复检。以免疫印迹法的检测结果为标准,计算单一方法检测及多种方法联合检测的阳性预测值,并建立孕妇梅毒血清学筛查流程。结果 548例孕妇血清样本中,免疫印迹法阳性494例、阴性43例、不确定11例(后续研究剔除这11例样本);TRUST阳性295例、阴性253例;CMIA阳性(S/CO值≥1.0)490例、阴性(S/CO值<1.0)58例。以免疫印迹法结果为标准,CLIA/TRUST/CMIA(+/-/-)、CLIA/TRUST(+/-)、CLIA/TRUST/CMIA(+/-/+)、CLIA/TRUST(+/+)和CLIA/TRUST/CMIA(+/+/+)的阳性预测值分别为22.4%、82.2%、97.4%、100.0%和100.0%。受试者工作特征(ROC)曲线分析结果显示,CLIA /TRUST/CMIA(+/-/+)组合中CMIA的最佳S/CO临界值为2.31,此时敏感性为94.7%、特异性为100.0%。根据以上结果建立孕妇梅毒血清学筛查流程:先采用CLIA初筛,如结果呈阴性则报告阴性,如呈阳性则加做TRUST;TRUST阳性报告阳性,阴性则采用CMIA复检;复检阳性且S/CO值≥2.31则报告阳性,复检阴性或虽呈阳性但S/CO值<2.31则加做免疫印迹法检测,最后根据免疫印迹法结果出具报告。结论 结合4种梅毒血清学试验方法建立了孕妇梅毒筛查流程,可在减少免疫印迹法复检的同时,提高孕妇梅毒诊断的准确性。

关键词: 梅毒螺旋体, 梅毒血清学试验, 筛查流程, 孕妇, 梅毒

Abstract:

Objective To investigate preliminarily the process of serological screening for syphilis in pregnant women. Methods A total of 548 serum samples of pregnant women with anti-Treponema pallidum(TP)antibody S/CO ratio ≥1.0 screened by chemiluminescence immunoassay(CLIA) were collected and were retested by chemiluminescence microparticle immunoassay(CMIA),toluidine red unheated serum test(TRUST) and western blotting. The positive predictive values of single method and combined method were analyzed respectively based on the western blotting results,and the serological screening process for syphilis in pregnant women was established. Results There were 548 samples with anti-TP antibody S/CO ratio ≥1.0 determined by CLIA,among which 494 cases were positive, 11 cases were indeterminate(eliminated), and 43 cases were negative determined by western blotting. Totally,295 samples were positive,and 253 samples were negative determined by TRUST. Totally, 490 samples were positive with S/CO ratio ≥1.0, and 58 samples were negative with S/CO ratio <1.0 determined by CMIA. The results of western blotting were used as gold standard, the positive predictive values of CLIA/TRUST/CMIA(+/-/-), CLIA/TRUST(+/-), CLIA/TRUST/CMIA(+/-/+), CLIA/TRUST(+/+) and CLIA/TRUST/CMIA(+/+/+)were 22.4%, 82.2%, 97.4%, 100.0% and 100.0%, respectively. According to the receiver operating characteristic(ROC) curve, the optimal anti-TP antibody S/CO ratio of CMIA was 2.31 among CLIA/TRUST/CMIA(+/-/+) samples,the sensitivity was 94.7%, and the specificity was 100.0%. The serological screening process for syphilis was established based on the above results:prescreening by CLIA,the negative result can be issued directly,and the positive result should be tested by TRUST;the positive result can be issued,but the negative result should be retested by CMIA;issue the positive result when the S/CO≥2.31,retested by western blotting when the result was negative or S/CO<2.31, and issue the report according to western blotting eventually. Conclusions The serological screening process for syphilis has been established through the combination of 4 syphilis serological methods, which can improve the accuracy of syphilis diagnosis in pregnant women while reducing reexamination by western blotting.

Key words: Treponema pallidum, Syphilis serological test, Screening process, Pregnant woman, Syphilis

中图分类号: